{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:05:16Z","timestamp":1765976716649,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.anai.2023.09.006","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T19:46:30Z","timestamp":1695325590000},"page":"689-690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Eosinophilic bronchiectasis and therapeutic opportunities"],"prefix":"10.1016","volume":"131","author":[{"given":"Grace","family":"Oscullo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Daniel","family":"Gomez-Olivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7321-1891","authenticated-orcid":false,"given":"Miguel \u00c1ngel","family":"Mart\u00ednez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.anai.2023.09.006_bib0001","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2213-2600(21)00277-0","article-title":"Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations","volume":"10","author":"Aliberti","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.anai.2023.09.006_bib0002","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.arbres.2021.11.003","article-title":"Treating neutrophilic inflammation in airways diseases","volume":"58","author":"Long","year":"2022","journal-title":"Arch Bronconeumol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.006_bib0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.arbres.2021.08.003","article-title":"The airway microbiome: present and future applications","volume":"58","author":"Aog\u00e1in","year":"2022","journal-title":"Arch Bronconeumol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.006_bib0004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.arbres.2021.10.003","article-title":"Global initiative for asthma strategy 2021. Executive summary and rationale for key changes","volume":"58","author":"Reddel","year":"2022","journal-title":"Arch Bronconeumol"},{"issue":"8","key":"10.1016\/j.anai.2023.09.006_bib0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/thx.53.8.685","article-title":"Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis","volume":"53","author":"Gaga","year":"1998","journal-title":"Thorax"},{"issue":"14","key":"10.1016\/j.anai.2023.09.006_bib0006","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s40265-022-01785-1","article-title":"Inhaled corticosteroids in adults with non-cystic fibrosis bronchiectasis: from bench to bedside. A narrative review","volume":"82","author":"Mart\u00ednez-Garc\u00eda","year":"2022","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.anai.2023.09.006_bib0007","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.arbres.2021.03.005","article-title":"Spanish COPD Guidelines (GesEPOC) 2021: updated Pharmacological treatment of stable COPD","volume":"58","author":"Miravitlles","year":"2022","journal-title":"Arch Bronconeumol"},{"issue":"8","key":"10.1016\/j.anai.2023.09.006_bib0008","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.202108-1889OC","article-title":"Characterisation of eosinophilic bronchiectasis: a European multicohort study","volume":"205","author":"Shoemark","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.anai.2023.09.006_bib0009","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.chest.2023.04.029","article-title":"The U-shaped relationship between eosinophil count and bronchiectasis severity: the effect of inhaled corticosteroids","volume":"164","author":"Mart\u00ednez-Garc\u00eda","year":"2023","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.anai.2023.09.006_bib0010","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.arbres.2022.01.014","article-title":"Is it time to readjust the doses of inhaled corticosteroids in COPD?","volume":"58","author":"Cos\u00edo","year":"2022","journal-title":"Arch Bronconeumol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623012590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623012590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:32:21Z","timestamp":1761053541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120623012590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1081120623012590"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2023.09.006","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophilic bronchiectasis and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2023.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}